13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001012975-23-000226
Total Value
$114.0M
Positions
10
Other Managers
0
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ISHARES TR | 46429B598 | 1,200,144 | $47.2M | 41.45% |
| 2 | 23ANDME HOLDING CO | 90138Q108 | 10,243,122 | $23.4M | 20.49% |
| 3 | PMV PHARMACEUTICALS INC | PMVP | 2,336,909 | $11.1M | 9.78% |
| 4 | RAPT THERAPEUTICS INC | 75382E109 | 432,900 | $7.9M | 6.97% |
| 5 | FOGHORN THERAPEUTICS INC | FHTX | 1,261,261 | $7.8M | 6.86% |
| 6 | ALECTOR INC | ALEC | 980,894 | $6.1M | 5.33% |
| 7 | ORIC PHARMACEUTICALS INC | ORIC | 747,550 | $4.3M | 3.74% |
| 8 | NGM BIOPHARMACEUTICALS INC | 62921N105 | 746,674 | $3.0M | 2.67% |
| 9 | TENAYA THERAPEUTICS INC | TNYA | 915,705 | $2.6M | 2.29% |
| 10 | SURROZEN INC | SRZNW | 802,963 | $483,384 | 0.42% |